Spindle Cell Variant of Rhabdomyosarcoma: An Aggressive Clinical Case of the Oral Cavity [0.03%]
横纹肌肉瘤的纺锤细胞性变异型：口腔的一种临床侵袭性病例报告
Mayadevi Poojari,Irappa Madabhavi
Mayadevi Poojari
Rhabdomyosarcoma (RMS) is a malignant, soft tissue neoplasm consisting of cells derived from the primitive mesenchyme that exhibit a profound tendency to myogenesis. Historically, the spindle cell and sclerosing variants were subcategorized...
Safety and Efficacy of Alectinib in the First Line for ALK-Mutated Lung Cancer: A Real-World Data from India [0.03%]
Alecensa一线治疗ROS1阳性非小细胞肺癌的疗效和安全性：印度真实世界数据
Ajaykumar Singh,Vanita Noronha,Vijay Patil et al.
Ajaykumar Singh et al.
Background: Advanced/metastatic ALK-mutated lung cancer has excellent long-term survival due availability of multiple targeted drugs. Alectinib is one of the preferred first-line therapies based on the Alex trial data. We...
Vikas Maheshwari,Mohit Dhingra,Divyansh Sharma et al.
Vikas Maheshwari et al.
Bone bank has become an essential requirement for centers that perform tumor and reconstructive surgeries. It provides allogenic bone procured from cadavers as well as live donors in the form of surgical residues. Thus, we conducted a retro...
Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, India [0.03%]
印度三级肿瘤中心EGFR突变非小细胞肺癌一线使用奥希替尼的真实世界经验
Atul Tiwari,Ajay Kumar Singh,Vanita Noronha et al.
Atul Tiwari et al.
Osimertinib is approved in the first line in patients with mutations in the sensitive gene epidermal growth factor receptor (EGFR) mutation. There is lack of real-world evidence to illustrate the effectiveness and safety of osimertinib that...
Comparative Analysis of Surgical Site Infections in Pediatric Brain Tumor Patients: Hygiene Practices, Risk Factors, and Implications for Healthcare Costs and Mortality [0.03%]
儿科脑肿瘤患者手术部位感染的比较分析：卫生习惯、风险因素及对医疗费用和死亡率的影响
Syed Ibrahim Bukhari,Muhammad Sohaib Shahid,Naureen Mushtaq et al.
Syed Ibrahim Bukhari et al.
Surgical site infections (SSIs) significantly impact pediatric central nervous system tumor outcomes. We present our data of SSIs and their influence on outcomes of pediatric brain tumor patients treated between January 2011 till December 2...
Exploring the Role of EZH2 and BCL2 in Demarcating Oral Verrucous Hyperplasia and Verrucous Carcinoma [0.03%]
探索EZH2和BCL2在区分口腔 verrucous hyperplasia 和 verrucous carcinoma 中的作用
Shreya Chatterjee,Anju Devi,Mala Kamboj et al.
Shreya Chatterjee et al.
Introduction: Oral verrucous hyperplasia (OVH) and verrucous carcinoma (OVC) are precursors of oral squamous cell carcinoma exhibiting overlapping histopathological picture which warrants distinction. EZH2 is an epigeneti...
Manjusha Deshpande,Amol Kokare
Manjusha Deshpande
Lung Cancer Sessions in Annual Conferences: Need for Better Interactions and Collaboration between Oncologists and Pulmonologists [0.03%]
肺癌领域肿瘤学家与呼吸科医生协作和交流的现状及未来——以ASH和ATS年会为例
Jayamol Revendran,Sujith Kumar Mullapally
Jayamol Revendran
Biological Dose Escalation-Do We Have a New Window of Opportunity in High-Grade Glioma?-A Feasibility Study [0.03%]
生物学剂量递增治疗-高级别脑胶质瘤中有新的机会之窗吗？一项可行性研究
Bindhu Joseph,Rasla Parween,Lokesh Vishwanath et al.
Bindhu Joseph et al.
Despite multimodality treatment in high-grade glioma (HGG) involving maximal safe resection and adjuvant chemoradiotherapy, the prognosis remains dismal. In this study, we aimed to evaluate a method of biological enhancement by combining do...
Free Fibula Reconstruction for Bone Tumors Involving Humerus: Our Experience [0.03%]
游离腓骨移植治疗累及肱骨的骨肿瘤——我们的经验
Bibhuti Bhusan Borthakur,Sumanjit Boro,Ashutosh Sahewalla
Bibhuti Bhusan Borthakur
Background: Malignant primary bone tumors constitute only 0.2% of all malignancies in adults and approximately 5% of childhood malignancies. The humerus is a common site for malignancies like chondrosarcoma, osteosarcoma,...